|
|
See Category: Neoplasms
See Header: Malignant carcinoid tumors
ICD-10 (CM) Code and Descriptor
|
C7A.00 |
Malignant carcinoid tumor of unspecified site
|
C7A00 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 57.57%
|
21.85%
|
9.10%
|
4.44%
|
2.54%
|
1.51%
|
0.86%
|
0.82%
|
0.52%
|
0.17%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C7A.00*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
2,991
|
3,295
|
|
J2353
|
OCTREOTIDE INJECTION, DEPOT |
2,362
|
69,843
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
2,218
|
2,219
|
|
80053
|
COMPREHEN METABOLIC PANEL |
2,201
|
2,201
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,939
|
1,943
|
|
86316
|
IMMUNOASSAY TUMOR OTHER |
1,410
|
1,412
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,392
|
1,398
|
|
J1930
|
LANREOTIDE INJECTION |
886
|
103,673
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
437
|
39,933
|
|
84260
|
ASSAY OF SEROTONIN |
376
|
377
|
|
71260
|
CT THORAX DX C+ |
343
|
344
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
341
|
342
|
|
82565
|
ASSAY OF CREATININE |
218
|
219
|
|
96402
|
CHEMO HORMON ANTINEOPL SQ/IM |
195
|
201
|
|
G1004
|
CDSM NDSC |
193
|
273
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
191
|
191
|
|
82728
|
ASSAY OF FERRITIN |
164
|
164
|
|
J3420
|
VITAMIN B12 INJECTION |
163
|
163
|
|
83735
|
ASSAY OF MAGNESIUM |
157
|
157
|
|
84443
|
ASSAY THYROID STIM HORMONE |
155
|
155
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C7A.00 related to the following DRG Codes:
826-828
829-830
843-845
|
